The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Simcere Zaiming, Inc. | Insider | Sell(S) | 30K | $6.16 | $185K |
| Jul 31, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy(P) | 3K | $4.98 | $16K |
| Jul 31, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy(P) | 25K | $4.98 | $125K |
| Jul 31, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy(P) | 8K | $4.80 | $38K |
| Jul 30, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy(P) | 50K | $4.97 | $249K |
| Jul 30, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy(P) | 20K | $5.00 | $100K |
| Jul 30, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy(P) | 20K | $5.00 | $100K |
| Jul 30, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy(P) | 25K | $4.81 | $120K |
| Jul 30, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy(P) | 100K | $4.90 | $490K |
| Jul 30, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy(P) | 78K | $4.96 | $386K |
| Jul 29, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy(P) | 2K | $5.00 | $9K |
| Jul 29, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy(P) | 2K | $5.00 | $8K |
| Jul 28, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy(P) | 6K | $4.95 | $32K |
| Jul 27, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy(P) | 8K | $5.00 | $39K |
| Jun 18, 2026 | Feigal Ellen | Director | Grant(A) | 2K | — | $0 |
| Jun 18, 2026 | Jones Elaine V | Director | Grant(A) | 2K | — | $0 |
| Jun 18, 2026 | Borgman Anne Elizabeth | Director | Grant(A) | 2K | — | $0 |
| Jun 18, 2026 | Webster Stephen W | Director | Grant(A) | 2K | — | $0 |
| Jun 18, 2026 | Houston John G | Director | Grant(A) | 2K | — | $0 |
| Jun 18, 2026 | Kabakoff David S | Director | Grant(A) | 4K | — | $0 |
| Jan 30, 2026 | Cobourn Steven P. | Chief Financial Officer | Grant(A) | 15K | — | $0 |
| Jan 30, 2026 | Guha Udayan | Chief Medical Officer | Grant(A) | 15K | — | $0 |
| Jan 30, 2026 | Mayer Timothy | Chief Operating Officer | Grant(A) | 15K | — | $0 |
| Jan 30, 2026 | Kundu Sourav | Sr VP, Dev. & Mfg. | Grant(A) | 8K | — | $0 |
| Jan 30, 2026 | Richman Michael | President & CEO, Director | Grant(A) | 38K | — | $0 |
| Jan 30, 2026 | Shaw Kevin G. | Sr VP, General Counsel | Grant(A) | 8K | — | $0 |
| Jun 20, 2025 | Feigal Ellen | Director | Grant(A) | 19K | — | $0 |
| Jun 20, 2025 | Webster Stephen W | Director | Grant(A) | 19K | — | $0 |
| Jun 20, 2025 | Borgman Anne Elizabeth | Director | Grant(A) | 19K | — | $0 |
| Jun 20, 2025 | Kabakoff David S | Director | Grant(A) | 28K | — | $0 |
| Jun 20, 2025 | Jones Elaine V | Director | Grant(A) | 19K | — | $0 |
| Jun 20, 2025 | Houston John G | Director | Grant(A) | 19K | — | $0 |
| Jan 31, 2025 | Richman Michael | President & CEO, Director | Grant(A) | 306K | — | $0 |
| Jan 31, 2025 | Cobourn Steven P. | Chief Financial Officer | Grant(A) | 117K | — | $0 |
| Jan 31, 2025 | Kundu Sourav | Sr VP, Dev. & Mfg. | Grant(A) | 66K | — | $0 |
| Jan 31, 2025 | Langermann Sol | Chief Scientific Officer | Grant(A) | 117K | — | $0 |
| Jan 31, 2025 | Mayer Timothy | Chief Operating Officer | Grant(A) | 117K | — | $0 |
| Jan 31, 2025 | Shaw Kevin G. | Sr VP, General Counsel | Grant(A) | 66K | — | $0 |
| Jun 20, 2024 | Borgman Anne Elizabeth | Director | Grant(A) | 19K | — | $0 |
| Jun 20, 2024 | Feigal Ellen | Director | Grant(A) | 19K | — | $0 |
| Jun 20, 2024 | Houston John G | Director | Grant(A) | 19K | — | $0 |
| Jun 20, 2024 | Jones Elaine V | Director | Grant(A) | 19K | — | $0 |
| Jun 20, 2024 | Kabakoff David S | Director | Grant(A) | 28K | — | $0 |
| Jun 20, 2024 | Webster Stephen W | Director | Grant(A) | 19K | — | $0 |
| Mar 29, 2024 | Cobourn Steven P. | Chief Financial Officer | Grant(A) | 94K | — | $0 |
| Mar 29, 2024 | Kundu Sourav | Sr VP, Dev. & Mfg. | Grant(A) | 53K | — | $0 |
| Mar 29, 2024 | Langermann Sol | Chief Scientific Officer | Grant(A) | 94K | — | $0 |
| Mar 29, 2024 | Mayer Timothy | Chief Operating Officer | Grant(A) | 94K | — | $0 |
| Mar 29, 2024 | Myint Han | Chief Medical Officer | Grant(A) | 94K | — | $0 |
| Mar 29, 2024 | Richman Michael | President & CEO, Director | Grant(A) | 244K | — | $0 |
| Mar 29, 2024 | Shaw Kevin G. | Sr VP, General Counsel | Grant(A) | 94K | — | $0 |
| Jan 31, 2024 | Cobourn Steven P. | Chief Financial Officer | Grant(A) | 117K | — | $0 |
| Jan 31, 2024 | Kundu Sourav | Sr VP, Dev. & Mfg. | Grant(A) | 66K | — | $0 |
| Jan 31, 2024 | Langermann Sol | Chief Scientific Officer | Grant(A) | 117K | — | $0 |
| Jan 31, 2024 | Mayer Timothy | Chief Operating Officer | Grant(A) | 117K | — | $0 |
| Jan 31, 2024 | Myint Han | Chief Medical Officer | Grant(A) | 117K | — | $0 |
| Jan 31, 2024 | Richman Michael | President & CEO, Director | Grant(A) | 306K | — | $0 |
| Jan 31, 2024 | Shaw Kevin G. | Sr VP, General Counsel | Grant(A) | 66K | — | $0 |
| Jun 22, 2023 | Borgman Anne Elizabeth | Director | Grant(A) | 14K | — | $0 |
| Jun 22, 2023 | Webster Stephen W | Director | Grant(A) | 14K | — | $0 |
| Jun 22, 2023 | Jones Elaine V | Director | Grant(A) | 14K | — | $0 |
| Jun 22, 2023 | Feigal Ellen | Director | Grant(A) | 14K | — | $0 |
| Jun 22, 2023 | Houston John G | Director | Grant(A) | 14K | — | $0 |
| Jun 22, 2023 | Khuong Chau Quang | Director | Grant(A) | 14K | — | $0 |
| Jun 22, 2023 | Kabakoff David S | Director | Grant(A) | 14K | — | $0 |
| Jun 22, 2023 | Nicholson Garry A | Director | Grant(A) | 14K | — | $0 |
| Feb 28, 2023 | Cobourn Steven P. | Chief Financial Officer | Grant(A) | 135K | — | $0 |
| Feb 28, 2023 | Richman Michael | President & CEO, Director | Grant(A) | 309K | — | $0 |
| Feb 28, 2023 | Langermann Sol | Chief Scientific Officer | Grant(A) | 135K | — | $0 |
| Feb 28, 2023 | Shaw Kevin G. | Sr VP, Legal Affairs | Grant(A) | 75K | — | $0 |
| Feb 28, 2023 | Myint Han | Chief Medical Officer | Grant(A) | 135K | — | $0 |
| Feb 28, 2023 | Kundu Sourav | Sr VP, Dev. & Mfg. | Grant(A) | 75K | — | $0 |
| Feb 28, 2023 | Mayer Timothy | Chief Operating Officer | Grant(A) | 135K | — | $0 |
| Jun 23, 2022 | Kabakoff David S | Director | Grant(A) | 14K | — | $0 |
| Jun 23, 2022 | Jones Elaine V | Director | Grant(A) | 14K | — | $0 |
| Jun 23, 2022 | Khuong Chau Quang | Director | Grant(A) | 14K | — | $0 |
| Jun 23, 2022 | Webster Stephen W | Director | Grant(A) | 14K | — | $0 |
| Jun 23, 2022 | Nicholson Garry A | Director | Grant(A) | 14K | — | $0 |
| Jun 23, 2022 | Houston John G | Director | Grant(A) | 14K | — | $0 |
| Jun 23, 2022 | Borgman Anne Elizabeth | Director | Grant(A) | 14K | — | $0 |
| Jun 23, 2022 | Feigal Ellen | Director | Grant(A) | 14K | — | $0 |
| Jan 31, 2022 | Myint Han | Chief Medical Officer | Grant(A) | 104K | — | $0 |
| Jan 31, 2022 | Cobourn Steven P. | Chief Financial Officer | Grant(A) | 97K | — | $0 |
| Jan 31, 2022 | Mayer Timothy | Chief Operating Officer | Grant(A) | 131K | — | $0 |
| Jan 31, 2022 | Richman Michael | President & CEO, Director | Grant(A) | 262K | — | $0 |
| Jan 31, 2022 | Kundu Sourav | Sr VP, Dev. & Mfg. | Grant(A) | 59K | — | $0 |
| Jan 31, 2022 | Langermann Sol | Chief Scientific Officer | Grant(A) | 117K | — | $0 |
| Jan 31, 2022 | Liu Linda | SVP, Research | Grant(A) | 66K | — | $0 |
| Oct 1, 2021 | Borgman Anne Elizabeth | Director | Grant(A) | 10K | — | $0 |
| Oct 1, 2021 | Borgman Anne Elizabeth | Director | Grant(A) | 29K | — | $0 |
| Oct 1, 2021 | Feigal Ellen | Director | Grant(A) | 29K | — | $0 |
| Oct 1, 2021 | Feigal Ellen | Director | Grant(A) | 10K | — | $0 |
| Jul 15, 2021 | Kundu Sourav | Sr VP, Dev. & Mfg. | Grant(A) | 150K | — | $0 |
| Jun 24, 2021 | Khuong Chau Quang | Director | Grant(A) | 14K | — | $0 |
| Jun 24, 2021 | Webster Stephen W | Director | Grant(A) | 14K | — | $0 |
| Jun 24, 2021 | Jones Elaine V | Director | Grant(A) | 14K | — | $0 |
| Jun 24, 2021 | Kabakoff David S | Director | Grant(A) | 14K | — | $0 |
| Jun 24, 2021 | Xu Stella | Director | Grant(A) | 14K | — | $0 |
| Jun 24, 2021 | Nicholson Garry A | Director | Grant(A) | 14K | — | $0 |
| Jun 24, 2021 | Houston John G | Director | Grant(A) | 14K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-08-28. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for NXTC